Back to Journals » Clinical Ophthalmology » Volume 11

Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”

Authors Ehrlich JR, Moroi SE

Received 21 April 2017

Accepted for publication 29 April 2017

Published 12 June 2017 Volume 2017:11 Pages 1119—1120

DOI https://doi.org/10.2147/OPTH.S140149

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser

Joshua R Ehrlich, Sayoko E Moroi

Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA

We read with great interest the article by Patodia et al entitled, “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.”1 The authors presented a pilot randomized controlled trial (RCT) in which subjects with glaucoma and low vision were assigned to observation or to receive standard low vision device(s). Using the Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48), the researchers found an improvement in reading ability and overall visual ability among those allocated to treatment compared to the control arm.
The authors correctly note that this is the first RCT to examine the effectiveness of low vision services for patients with glaucoma. In fact, there is also no rigorous evidence for the effectiveness of low vision interventions for patients with other causes of peripheral field loss (PFL) such as retinitis pigmentosa, hemianopia, or dense pan- retinal photogoagulation;2 this lack of evidence is concerning since around one-fifth of patients with low vision have been found to have significant PFL.3 Patodia et al1 point out that different patterns of functional impairment are likely to result from central and peripheral vision loss. Although this has been corroborated by prior research, there is still an inadequate qualitative understanding of how PFL affects patients’ day-to-day lives and how this is impacted by demographic and sociological features such as age, gender, culture, and place.

View the original paper by Patodia et al.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]